BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36265457)

  • 21. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
    Patil VM; Noronha V; Joshi A; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; Mahimkar M; Juvekar S; Arya S; Mahajan A; Agarwal A; Purandare N; Rangarajan V; Balaji A; Chaudhari SV; Banavali S; Kannan S; Bhattacharjee A; D'Cruz AK; Chaturvedi P; Pai PS; Chaukar D; Pantvaidya G; Nair D; Nair S; Deshmukh A; Thiagarajan S; Mathrudev V; Manjrekar A; Dhumal S; Maske K; Bhelekar AS; Nawale K; Chandrasekharan A; Pande N; Goel A; Talreja V; Simha V; Srinivas S; Swami R; Vallathol DH; Dsouza H; Shrirangwar S; Turkar S; Abraham G; Thanky AH; Patel U; Pandey MK; Prabhash K
    Cancer; 2019 Sep; 125(18):3184-3197. PubMed ID: 31150120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy.
    Sung S; Son SH; Kay CS; Lee YS
    Medicine (Baltimore); 2016 Mar; 95(10):e2965. PubMed ID: 26962798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.
    Adurthi S; Mukherjee G; Krishnamurthy H; Sudhir K; Bafna UD; Umadevi K; Jayshree RS
    Int J Gynecol Cancer; 2012 Sep; 22(7):1130-7. PubMed ID: 22872166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.
    Liu H; Ouyang X; Li Y; Zeng H; Wang X; Xie S; Nie D; Xiao J; Wei J; Wu Y; Yin S; Ma L
    Thromb Res; 2013 Aug; 132(2):196-201. PubMed ID: 23830211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer.
    Harima Y; Ohguri T; Imada H; Sakurai H; Ohno T; Hiraki Y; Tuji K; Tanaka M; Terashima H
    Int J Hyperthermia; 2016 Nov; 32(7):801-8. PubMed ID: 27418208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of CD4
    Shaobin W; Yu X; Jiatian L; Zaizhong C; Luping D; Junhui C
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C166-C170. PubMed ID: 28230011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal variation and prognostic significance of circulating immune cells in patients with nasopharyngeal carcinoma treated with chemoradiotherapy: a prospective cohort study.
    Huang C; Ding J; Huang C; Yu L; Chitapanarux I; Mejia MBA; Fei Z; Chen C
    Transl Cancer Res; 2023 Dec; 12(12):3718-3727. PubMed ID: 38192995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults.
    Shen E; Wang M; Xie H; Zou R; Lin Q; Lai L; Li F; Liang Z; Xu Y; Zhou M
    BMC Immunol; 2016 Jun; 17(1):20. PubMed ID: 27338754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity.
    Liang Y; Zeng Q; Wang XH; Yan L; Yu RH
    Biomed Res Int; 2023; 2023():5124034. PubMed ID: 36660452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma.
    Yang Q; Li G; Wu X; Lin H; Wu W; Xie X; Zhu Y; Cai W; Shi C; Zhuo S
    Front Oncol; 2023; 13():1136366. PubMed ID: 37064142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical observational study of Nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer].
    Chen J; Cao YJ; Zhu L; Zhang BL; Liu ZY; Hou HL; Chai YL; Wang P
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(8):597-601. PubMed ID: 33663192
    [No Abstract]   [Full Text] [Related]  

  • 33. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
    Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
    Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of changes in the expression levels of peripheral blood immunoregulatory T Lymphocytes in children with bronchial asthma accompanied by recurrent infection.
    Mi J; Guo Y
    Pak J Med Sci; 2022; 38(6):1520-1525. PubMed ID: 35991273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical features of imbalance between Th1 and Th22 cells and its association with disease progression in patients with liver cirrhosis].
    Wu HQ; Zhao JJ; Li HW; Zhang Z
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):738-744. PubMed ID: 29108201
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung Cancer: A Phase 2 Randomized Trial.
    Qiu B; Wang D; Li Q; Wu Y; Guo S; Jiang X; Fang J; Guo J; Liu F; Chu C; Wang B; Chen L; Zhang J; Liu Y; Hu Y; Liu H
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):917-925. PubMed ID: 34229051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Yiqi Tongyang Decoction () on blood T cell subsets in patients with chronic immune thrombocytopenia.
    Yang XP; Ma R; Yang XH; Zhu HL; Xu YG
    Chin J Integr Med; 2017 Sep; 23(9):709-713. PubMed ID: 27933513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets.
    Tada N; Kawai K; Tsuno NH; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Oba K; Watanabe T
    World J Surg Oncol; 2015 Feb; 13():30. PubMed ID: 25890185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
    Yan Y; Wang X; Liu C; Jia J
    BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.